Dr Kudakwashe Chani
Head, AMR-One Health
Working groups
Background
Dr Kudakwashe Chani is the head of the AMR-One Health working group at Burnet. He has extensive experience in managing large and complex public health programs in Southern Africa, Australia, and the Pacific.
Qualifications
- 2013: MBA, Regent Business School, South Africa;
- 2011: MPH, University of South Africa, South Africa;
- 1997: MBChB, University of Zimbabwe, Zimbabwe
Positions
2025–current: Head, Antimicrobial Resistance and One Health Working Group & Senior Research Fellow, Burnet Institute, Australia
2022–2025: Country Director, Burnet Institute, Papua New Guinea
2019–2022: Consulting roles - Public Health Specialist (Samoa and Tonga), IPM/Abt Associates, Australia, Health systems strengthening specialist (Burnet Institute), and Advisor (Australian National University);
2020: Assistant Director/Epidemiologist, Australian Department of Health (Non ongoing role);
2019: Senior Technical Lead, International Health, SHS/Abt Associates, Canberra, Australia;
2017–2019: Country Director & TB Technical Director, Burnet Institute, Papua New Guinea;
2017: Team Leader, RID-TB Project, Burnet Institute, Western Province, Papua New Guinea;
2015–2016: Deputy Chief of Party/Clinical Director, Society for Family Health, Namibia;
2013–2015: Executive Director, Catholic AIDS Action, Namibia;
2009–2013: Technical Director, IntraHealth International, Namibia;
2007–2009: Program Manager/Chief Medical Officer, Catholic Health Services, Namibia;
1997–2007: Various medical officer roles with Ministry of Health and Child Care (Zimbabwe), Catholic Health Services (Namibia), Ministry of Health and Social Services/Global Fund (Namibia)
Burnet publications
View 1 moreAntimicrobial resistance of bacteria isolated from blood cultures at a tertiary hospital in Papua New Guinea: implications for antimicrobial stewardship and surveillance
Frontiers in Public Health
Watson Toroi et al
Proportions of Xpert MTB/RIF Ultra ‘trace’ results vary widely among different populations with presumptive TB
The International Journal of Tuberculosis and Lung Disease
Kudakwashe Chani et al
Evaluating the impact of Xpert® MTB/RIF on mortality from TB: are we asking the right questions?
Public Health Action
Kudakwashe Chani et al